A phase III trial, the High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) trial, recruiting term or near term infants with moderate or severe HIE has recently published their data and reported that there was no added benefit to the administration of Epo with TH than TH alone. This evidence concerns the gene EPO and perinatal asphyxia.